all report title image

TAMIFLU (OSELTAMIVIR PHOSPHATE) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Tamiflu (Oseltamivir Phosphate) Market, by Drug Type (Branded and Generic), by Dosage Form (Capsules and Suspension), by Indication (Influenza A, Influenza B, and Swine Flu (H1N1 Influenza A)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

  • Published In: 29 Apr, 2026
  • Code: CMI5489
  • Page number: 180
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Dosage Form
      • Market Snapshot, By Indication
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Attractiveness Analysis
      • Market Opportunities
    • Product Launches
    • Market Trends
    • Merger, Acquisition, Collaborations
    • Regulatory Guideline and Compliances
    • Key Developments
    • PEST Analysis
    • Technology Landscape
    • Pricing Analysis (2022)
  4. Global Tamiflu (Oseltamivir Phosphate) Market, By Drug Type, 2021 – 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Branded
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Generic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
  5. Global Tamiflu (Oseltamivir Phosphate) Market, By Dosage Form, 2021 – 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Capsules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Suspension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
  6. Global Tamiflu (Oseltamivir Phosphate) Market, By Indication, 2021 – 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segments Trends
    • Influenza A
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Influenza B
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Swine Flu (H1N1 Influenza A)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
  7. Global Tamiflu (Oseltamivir Phosphate) Market, By Distribution Channel, 2021 – 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segments Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
  8. Global Tamiflu (Oseltamivir Phosphate) Market, By Region, 2021 – 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • F.Hoffmann-La Roche Ltd.*
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • NATCO Pharma Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LUPIN Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Amneal Pharmaceuticals LLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Zydus Cadila
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sun Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Alembic Pharmaceuticals Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mylan N.V
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Hetero Group
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  10. Section

    • Research Methodology
    • About Us

*Browse 29 market data tables and 22 figures on “Global Tamiflu (Oseltamivir Phosphate) Market” - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.